100 related articles for article (PubMed ID: 30518632)
1. Eradication of Central Nervous System Leukemia of T-Cell Origin with a Brain-Permeable LSD1 Inhibitor.
Saito S; Kikuchi J; Koyama D; Sato S; Koyama H; Osada N; Kuroda Y; Akahane K; Inukai T; Umehara T; Furukawa Y
Clin Cancer Res; 2019 Mar; 25(5):1601-1611. PubMed ID: 30518632
[TBL] [Abstract][Full Text] [Related]
2. Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.
Li Y; Deng C; Hu X; Patel B; Fu X; Qiu Y; Brand M; Zhao K; Huang S
Oncogene; 2012 Nov; 31(48):5007-18. PubMed ID: 22310283
[TBL] [Abstract][Full Text] [Related]
3. The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy.
Liu H; Wei J; Sang N; Zhong X; Zhou X; Yang X; Zhang J; Zuo Z; Zhou Y; Yang S; Du J; Zhao Y
Med Oncol; 2021 Sep; 38(10):124. PubMed ID: 34491469
[TBL] [Abstract][Full Text] [Related]
4. ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia.
Maes T; Mascaró C; Tirapu I; Estiarte A; Ciceri F; Lunardi S; Guibourt N; Perdones A; Lufino MMP; Somervaille TCP; Wiseman DH; Duy C; Melnick A; Willekens C; Ortega A; Martinell M; Valls N; Kurz G; Fyfe M; Castro-Palomino JC; Buesa C
Cancer Cell; 2018 Mar; 33(3):495-511.e12. PubMed ID: 29502954
[TBL] [Abstract][Full Text] [Related]
5. LSD1/KDM1A inhibitors in clinical trials: advances and prospects.
Fang Y; Liao G; Yu B
J Hematol Oncol; 2019 Dec; 12(1):129. PubMed ID: 31801559
[TBL] [Abstract][Full Text] [Related]
6. ToTAL1y degraded - rapid dTAG proteolysis of TAL1 in T-cell acute lymphoblastic leukemia.
Costa JR; Mansour MR
Haematologica; 2024 May; 109(5):1325-1327. PubMed ID: 38105739
[No Abstract] [Full Text] [Related]
7. Thymus-Brain Connections in T-Cell Acute Lymphoblastic Leukemia.
Mendes-da-Cruz DA; Belorio EP; Cotta-de-Almeida V
Neuroimmunomodulation; 2024; 31(1):51-61. PubMed ID: 38272012
[TBL] [Abstract][Full Text] [Related]
8. Non-toxic polymer nanovectors for improved delivery of dexamethasone.
Ede BC; Diamanti P; Williams DS; Blair A
Sci Rep; 2021 Aug; 11(1):17263. PubMed ID: 34446801
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin Hydroxy Acid Fails to Attain Sufficient Central Nervous System Tumor Exposure to Achieve a Cytotoxic Effect: Results of a Preclinical Cerebral Microdialysis Study.
Patel YT; Jacus MO; Davis AD; Boulos N; Turner DC; Vuppala PK; Freeman BB; Gilbertson RJ; Stewart CF
Drug Metab Dispos; 2016 Apr; 44(4):591-4. PubMed ID: 26802130
[TBL] [Abstract][Full Text] [Related]
10. B cells turn on, tune in with LSD1.
Good-Jacobson KL
Nat Immunol; 2019 Jan; 20(1):3-5. PubMed ID: 30538329
[No Abstract] [Full Text] [Related]
11. PARP1-LSD1 functional interplay controls transcription of SOD2 that protects human pro-inflammatory macrophages from death under an oxidative condition.
Tokarz P; Płoszaj T; Regdon Z; Virág L; Robaszkiewicz A
Free Radic Biol Med; 2019 Feb; 131():218-224. PubMed ID: 30529301
[TBL] [Abstract][Full Text] [Related]
12. T-448, a specific inhibitor of LSD1 enzyme activity, improves learning function without causing thrombocytopenia in mice.
Matsuda S; Baba R; Oki H; Morimoto S; Toyofuku M; Igaki S; Kamada Y; Iwasaki S; Matsumiya K; Hibino R; Kamada H; Hirakawa T; Iwatani M; Tsuchida K; Hara R; Ito M; Kimura H
Neuropsychopharmacology; 2019 Jul; 44(8):1505-1512. PubMed ID: 30580376
[TBL] [Abstract][Full Text] [Related]
13. Sox2 is associated with cancer stem-like properties in colorectal cancer.
Takeda K; Mizushima T; Yokoyama Y; Hirose H; Wu X; Qian Y; Ikehata K; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Doki Y; Mori M; Yamamoto H
Sci Rep; 2018 Dec; 8(1):17639. PubMed ID: 30518951
[TBL] [Abstract][Full Text] [Related]
14. Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer.
Gao S; Chen S; Han D; Wang Z; Li M; Han W; Besschetnova A; Liu M; Zhou F; Barrett D; Luong MP; Owiredu J; Liang Y; Ahmed M; Petricca J; Patalano S; Macoska JA; Corey E; Chen S; Balk SP; He HH; Cai C
Nat Genet; 2020 Oct; 52(10):1011-1017. PubMed ID: 32868907
[TBL] [Abstract][Full Text] [Related]
15. LSD1-mediated enhancer silencing attenuates retinoic acid signalling during pancreatic endocrine cell development.
Vinckier NK; Patel NA; Geusz RJ; Wang A; Wang J; Matta I; Harrington AR; Wortham M; Wetton N; Wang J; Jhala US; Rosenfeld MG; Benner CW; Shih HP; Sander M
Nat Commun; 2020 Apr; 11(1):2082. PubMed ID: 32350257
[TBL] [Abstract][Full Text] [Related]
16. Lysine-specific demethylase 1 as a therapeutic cancer target: observations from preclinical study.
Johnson JD; Alejo S; Jayamohan S; Sareddy GR
Expert Opin Ther Targets; 2023; 27(12):1177-1188. PubMed ID: 37997756
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of adult central nervous system leukemia.
Liu S; Wang Y
Blood Sci; 2023 Jul; 5(3):141-149. PubMed ID: 37546706
[TBL] [Abstract][Full Text] [Related]
18. Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies.
Gaál Z
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671446
[TBL] [Abstract][Full Text] [Related]
19. Structure-Activity Relationship and
Niwa H; Watanabe C; Sato S; Harada T; Watanabe H; Tabusa R; Fukasawa S; Shiobara A; Hashimoto T; Ohno O; Nakamura K; Tsuganezawa K; Tanaka A; Shirouzu M; Honma T; Matsuno K; Umehara T
ACS Med Chem Lett; 2022 Sep; 13(9):1485-1492. PubMed ID: 36105323
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
